156 related articles for article (PubMed ID: 22892900)
1. Life events may contribute to family communication about cancer risk following BRCA1/2 testing.
Lapointe J; Côté C; Bouchard K; Godard B; Simard J; Dorval M
J Genet Couns; 2013 Apr; 22(2):249-57. PubMed ID: 22892900
[TBL] [Abstract][Full Text] [Related]
2. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
Chopra I; Kelly KM
J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
[TBL] [Abstract][Full Text] [Related]
4. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
[TBL] [Abstract][Full Text] [Related]
6. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
7. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.
Fehniger J; Lin F; Beattie MS; Joseph G; Kaplan C
J Genet Couns; 2013 Oct; 22(5):603-12. PubMed ID: 23666114
[TBL] [Abstract][Full Text] [Related]
10. Talking across generations: Family communication about BRCA1 and BRCA2 genetic cancer risk.
Young AL; Butow PN; Rhodes P; Tucker KM; Williams R; Healey E; Wakefield CE
J Genet Couns; 2019 Jun; 28(3):516-532. PubMed ID: 30694012
[TBL] [Abstract][Full Text] [Related]
11. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
[TBL] [Abstract][Full Text] [Related]
12. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
13. Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.
Dancyger C; Wiseman M; Jacobs C; Smith JA; Wallace M; Michie S
Psychol Health; 2011 Aug; 26(8):1018-35. PubMed ID: 21797732
[TBL] [Abstract][Full Text] [Related]
14. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
15. Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
Crotser CB; Dickerson SS
J Nurs Scholarsh; 2010 Dec; 42(4):367-78. PubMed ID: 21091619
[TBL] [Abstract][Full Text] [Related]
16. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
17. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
Seven M; Shah LL; Daack-Hirsch S; Yazici H
Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
[TBL] [Abstract][Full Text] [Related]
18. Life after BRCA1/2 testing: family communication and support issues.
DeMarco TA; McKinnon WC
Breast Dis; 2006-2007; 27():127-36. PubMed ID: 17917144
[TBL] [Abstract][Full Text] [Related]
19. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
[TBL] [Abstract][Full Text] [Related]
20. Communication of BRCA results and family testing in 1,103 high-risk women.
Cheung EL; Olson AD; Yu TM; Han PZ; Beattie MS
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2211-9. PubMed ID: 20699375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
